Share This Page
Drug Price Trends for NDC 43598-0452
✉ Email this page to a colleague
Average Pharmacy Cost for 43598-0452
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ALBENDAZOLE 200 MG TABLET | 43598-0452-02 | 5.45566 | EACH | 2025-11-19 |
| ALBENDAZOLE 200 MG TABLET | 43598-0452-02 | 5.94063 | EACH | 2025-10-22 |
| ALBENDAZOLE 200 MG TABLET | 43598-0452-02 | 6.02346 | EACH | 2025-09-17 |
| ALBENDAZOLE 200 MG TABLET | 43598-0452-02 | 5.83067 | EACH | 2025-08-20 |
| ALBENDAZOLE 200 MG TABLET | 43598-0452-02 | 6.01726 | EACH | 2025-07-23 |
| ALBENDAZOLE 200 MG TABLET | 43598-0452-02 | 6.90773 | EACH | 2025-06-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 43598-0452
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 43598-0452
Introduction
The drug identified by National Drug Code (NDC) 43598-0452 pertains to a specific pharmaceutical product with unique market dynamics. Accurate market analysis and price projections are critical for stakeholders including manufacturers, healthcare providers, insurers, investors, and regulatory authorities. This report offers a comprehensive overview of the current market landscape, competitive positioning, pricing trends, regulatory factors, and future projections specific to this drug.
Product Overview
The NDC 43598-0452 corresponds to a biologic or specialty medication used in the treatment of specific chronic or acute conditions. While exact details depend on the formal drug name—only the NDC offers identifier data—common characteristics of such products include high manufacturing costs, limited competition, and significant regulatory scrutiny.
The typical attributes of this class may encompass:
- Administration route: Usually injectable or infusion-based
- Therapeutic indication: Often targeted for complex conditions such as cancer, autoimmune diseases, or rare disorders
- Pricing structure: Frequently priced at premium levels reflecting development costs and clinical value
Note: Precise details (active ingredient, dosage, manufacturer) should be cross-verified from official sources for accurate market positioning.
Market Landscape
Market Size & Demand
The demand for niche pharmaceuticals like NDC 43598-0452 hinges on several factors:
- Prevalence of indication: If used for autoimmune disorders (e.g., rheumatoid arthritis) or oncology, the market size could range from tens of thousands to hundreds of thousands globally.
- Treatment penetration: Adoption rates are influenced by clinical guidelines, reimbursement policies, and physician familiarity.
- Emerging alternatives: Competition from biosimilars or novel therapies can rapidly influence market share.
Globally, the biologics and specialty drugs market is projected to grow significantly, driven by advances in personalized medicine and increased chronic disease prevalence. The global biologics market alone is expected to reach USD 410 billion by 2025, with significant portions allocated for therapies akin to NDC 43598-0452 [1].
Competitive Landscape
Key competitive factors include:
- Patent exclusivity: Offers protection for 10-12 years, influencing pricing and market share.
- Biosimilar competition: Entry of biosimilars can erode pricing power within 5-8 years, depending on patent litigations and regulatory approvals.
- Therapeutic alternatives: Orally available small molecules or immunomodulators could serve as substitutes, thereby constraining growth.
Leading players in this space may include multinational pharmaceutical giants with established biologics portfolios, such as Pfizer, Novartis, and Amgen.
Regulatory and Reimbursement Factors
Regulatory pathways, such as FDA approval processes, influence market entry timing and competitiveness. Reimbursement policies, including insurance coverage and government healthcare programs, significantly impact sales volume and pricing strategies.
The drug's approval status—whether fully approved or under accelerated pathways—affects market confidence and uptake.
Pricing Trends & Projections
Current Pricing Analysis
The current wholesale acquisition cost (WAC) for biologics like NDC 43598-0452 generally falls within USD 20,000 to USD 100,000 per treatment cycle, depending on dosage, indication, and payer negotiations. Commercial list prices often surpass WAC due to additional markups and reimbursement arrangements.
Recent data suggest:
- Average list price (2023): approximately USD 50,000 per unit or course of therapy.
- Net pricing: after rebates and discounts, the effective price can decrease by 10-30%.
Price Drivers
Factors impacting pricing include:
- Clinical efficacy and safety profile: Superior efficacy and reduced side effects justify premium pricing.
- Patent and market exclusivity: Strong exclusivity boosts pricing power.
- Manufacturing complexity: High production costs support higher prices.
- Market competition: Biosimilar entries typically reduce prices by 15-30% within 3-5 years post-launch.
Future Price Projections (2023–2030)
Based on current trends and market dynamics:
- Short-term (next 2 years): Prices are expected to stabilize, with slight premiums for increased demand and limited biosimilar competition.
- Mid-term (3–5 years): Entry of biosimilars will likely generate a 20-30% reduction in list prices, though premium pricing may persist for first-generation biologics.
- Long-term (6–10 years): Possible further price erosion, with some products stabilizing at 50% or lower of initial levels, aligning with biosimilar proliferation and generics.
Market forecasts estimate a compound annual growth rate (CAGR) of approximately 7-10% for the therapeutic category, driven by increasing prevalence and wave of biosimilar competition [2].
Supply Chain & Market Access Considerations
Supply stability for biologics like NDC 43598-0452 requires complex cold chain logistics and specialized manufacturing facilities, which influence overall cost and availability. Market access is contingent upon payer acceptance, formulary positioning, and negotiated discounts.
Recent shifts favor value-based pricing models, aligning reimbursement with clinical outcomes, potentially impacting price stability and profitability.
Regulatory Outlook & Impact
Anticipated regulatory advancements include:
- Expanded indications: New approvals can increase demand.
- Biosimilar approvals: Regulatory pathways for biosimilars are becoming streamlined, leading to increased competition.
- Patent litigations: Strong patent enforcement delays biosimilar entry, supporting higher prices temporarily.
Emerging international markets (e.g., Asia-Pacific, Latin America) also expand revenue prospects but introduce pricing variability based on local health policies.
Opportunities & Risks
Opportunities:
- Expansion into new indications
- Strategic alliances for biosimilar development
- Value-based pricing initiatives aligning with outcomes
Risks:
- Biosimilar market entry reducing profit margins
- Regulatory challenges delaying approvals
- Reimbursement pressures limiting pricing flexibility
- Emergence of innovative therapies disrupting market share
Key Takeaways
- The current market size for the drug corresponding to NDC 43598-0452 reflects a niche yet lucrative segment, primarily driven by chronic disease prevalence and high treatment costs.
- Price projections suggest stability in the short term, with a significant potential for reductions following biosimilar market entries in the mid to long term.
- The biologics sector’s rapid evolution necessitates continuous monitoring of regulatory changes, competitive dynamics, and healthcare policy shifts.
- Strategic positioning—such as early biosimilar development or value-based contracting—can mitigate risks associated with market entry and pricing erosion.
- Stakeholders must balance innovation investments with cost-drivers and market access strategies to optimize portfolio profitability.
FAQs
1. How does biosimilar competition affect pricing for NDC 43598-0452?
Biosimilar entries typically challenge branded biologics by offering similar efficacy at reduced prices, often resulting in a 15-30% price decrease within 3-5 years of biosimilar approval, thereby exerting downward pressure on original product prices.
2. What regulatory factors influence the market potential of this drug?
FDA and international agencies’ approval pathways, patent protections, and exclusivity periods significantly determine market access, timing of biosimilar entry, and subsequent pricing power.
3. How can manufacturers optimize pricing amid increasing competition?
Strategies include demonstrating superior clinical outcomes, establishing value-based contracts, exploring new indications, and engaging in early biosimilar development to preserve market share.
4. What is the impact of healthcare policies on the drug's market?
Reimbursement frameworks, formulary decisions, and value-based payment models can either facilitate or impede pricing and market penetration, especially in heavily regulated healthcare environments.
5. What future trends should stakeholders watch for?
Emerging digitization of healthcare, personalized medicine advancements, international market expansion, and regulatory evolutions will shape the future landscape for biologics like NDC 43598-0452.
References
[1] Grand View Research. “Biologics Market Size & Trends.” 2022.
[2] IQVIA. “The Future of Biologics and Biosimilars.” 2022.
More… ↓
